Company
Company
Search

Biotech & Health

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that.

Biotech & Health /

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: if someone does have cancer, is an aggressive treatment like chemotherapy […]

Not all cancer patients need chemo. Ataraxis AI raised $20M to fix that. Read More »

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment

Biotech & Health /

Artificial intelligence is a big trend in cancer care, and it’s mostly focused on detecting cancer at the earliest possible stage. That makes a lot of sense, given that cancer is less deadly the earlier it’s detected. But fewer are asking another fundamental question: If someone does have cancer, is an aggressive treatment like chemotherapy

Not all cancer patients need chemo — Ataraxis AI raised $20M to personalize treatment Read More »

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse

Biotech & Health /

Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming steady progress. It’s evidence: Genetically engineering mice to have mammoth-like fur. To engineer the woolly mouse, the company’s scientists found mouse versions of mammoth genes and then used CRISPR to edit mice embryos, Dr. Beth Shapiro, chief science officer

On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse Read More »

Startup co-founded by longevity guru Peter Attia emerges from stealth

Biotech & Health /

Longevity is a hot trend in Silicon Valley these days, driven by rising interest—especially among the wealthy—in preventing disease through regular testing. A new player, Biograph, has just emerged from stealth, and it’s co-founded by one of the biggest names in longevity science: Dr. Peter Attia. Attia is a Canadian-American physician best known as the

Startup co-founded by longevity guru Peter Attia emerges from stealth Read More »

Stripe finalizes tender sale at a $91.5B valuation, says payment volumes grew to $1.4T in 2024

Biotech & Health /

Digital payments platform has yet to lay out plans to go public, but in the meantime the company has thrown past and present employees a line for some liquidity. The company on Thursday confirmed a tender offer where investors will buy up shares from those employees at a valuation of $91.5 billion. Stripe said it

Stripe finalizes tender sale at a $91.5B valuation, says payment volumes grew to $1.4T in 2024 Read More »

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis

Biotech & Health /

Canadian biotech startup Afynia Laboratories, a spin-out from McMaster University in Ontario, has picked up $5 million in seed funding to commercialize a blood test for endometriosis — a medical condition that can afflict people with a uterus, causing problems like chronic pelvic pain and fertility issues. Endometriosis affects nearly 200 million people worldwide. Getting

University spin-out Afynia secures $5M seed to commercialize its microRNA panel test for endometriosis Read More »

Holmes and Balwani’s appeal falls flat as court upholds fraud convictions

Biotech & Health /

Elizabeth Holmes and Ramesh “Sunny” Balwani’s appeals to overturn their fraud convictions and reduce their prison sentences were denied Monday by the Northern District Court of California, which also refused to soften their $452 million joint restitution order. Holmes, the founder of Theranos, and Balwani, its former COO, were convicted in separate trials in 2022

Holmes and Balwani’s appeal falls flat as court upholds fraud convictions Read More »

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech

Biotech & Health /

Tiny Michigan biotech startup CircNova has raised a $3.3 million seed round for its technology that uses AI to target so-called “circular RNA.” The development holds promise as a new method to quickly develop therapies for conditions that currently have no drug treatments. The new funding is also a victory lap for co-founder and CEO

How automotive exec Crystal Brown founded CircNova, an AI drug discovery biotech Read More »

Spore.Bio raises $23M to apply machine learning to microbiology testing

Biotech & Health /

Recalls in the food and beverage industry due to contamination incidents can have catastrophic effects. Not only do companies have to pay fines and damages, but the impacts on the brand’s reputation can be long-lasting. That’s why Spore.Bio, a Paris-based deeptech startup, is trying to reinvent microbiology testing to avoid the next PR crisis in

Spore.Bio raises $23M to apply machine learning to microbiology testing Read More »